Communicating medication risks in pregnancy: Towards shared decision making
Medication use during pregnancy is common, yet safety data remain limited, often leading to exaggerated risk perceptions and suboptimal care. Current communication practices are fragmented: product labeling and patient leaflets tend to emphasize potential harms, while specialized resources are under...
| Published in: | Frontiers in Drug Safety and Regulation |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-10-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2025.1712216/full |
| _version_ | 1848680503177117696 |
|---|---|
| author | Ursula Winterfeld Kenneth Hodson Kenneth Hodson Maya Berlin Benoît Marin Michael Ceulemans Michael Ceulemans Michael Ceulemans Corinna Weber-Schoendorfer François R. Girardin David Baud Béatrice Schaad Béatrice Schaad Alice Panchaud Alice Panchaud |
| author_facet | Ursula Winterfeld Kenneth Hodson Kenneth Hodson Maya Berlin Benoît Marin Michael Ceulemans Michael Ceulemans Michael Ceulemans Corinna Weber-Schoendorfer François R. Girardin David Baud Béatrice Schaad Béatrice Schaad Alice Panchaud Alice Panchaud |
| author_sort | Ursula Winterfeld |
| collection | DOAJ |
| container_title | Frontiers in Drug Safety and Regulation |
| description | Medication use during pregnancy is common, yet safety data remain limited, often leading to exaggerated risk perceptions and suboptimal care. Current communication practices are fragmented: product labeling and patient leaflets tend to emphasize potential harms, while specialized resources are underused. We explore the challenges of conveying accurate risk-benefit information and highlight the need for shared decision making. Integrated, evidence-based resources accessible to both healthcare providers and patients can reduce misinformation, improve adherence to essential treatments, and ultimately enhance maternal and child health. The Swiss MAMA-MEDS initiative illustrates how a unified knowledge base can align messaging, address health inequalities, and support patient-centered pregnancy care. |
| format | Article |
| id | doaj-art-d03e27b14e2b4ee7bc2babb345db851c |
| institution | Directory of Open Access Journals |
| issn | 2674-0869 |
| language | English |
| publishDate | 2025-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| spelling | doaj-art-d03e27b14e2b4ee7bc2babb345db851c2025-10-22T10:04:36ZengFrontiers Media S.A.Frontiers in Drug Safety and Regulation2674-08692025-10-01510.3389/fdsfr.2025.17122161712216Communicating medication risks in pregnancy: Towards shared decision makingUrsula Winterfeld0Kenneth Hodson1Kenneth Hodson2Maya Berlin3Benoît Marin4Michael Ceulemans5Michael Ceulemans6Michael Ceulemans7Corinna Weber-Schoendorfer8François R. Girardin9David Baud10Béatrice Schaad11Béatrice Schaad12Alice Panchaud13Alice Panchaud14Swiss Teratogen Information Service and Clinical Pharmacology Service, Lausanne University Hospital, Lausanne, SwitzerlandUK Teratology Information Service, Newcastle uponTyne, United KingdomDirectorate of Women’s Services, Royal Victoria Infirmary, Newcastle uponTyne, United KingdomClinical Pharmacology and Toxicology Unit, Drug Consultation Center, Shamir Medical Center affiliated with Faculty of Medical & Health Science, Tel Aviv University, Tel Aviv, IsraelDépartement de Santé Publique, Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpital Trousseau, Centre de Référence sur les Agents Tératogènes (CRAT), Paris, FranceDepartment of Pharmaceutical and Pharmacological Sciences, Leuven, BelgiumKU Leuven Child & Youth Institute, Leuven, BelgiumIQ Health, Radboud University Medical Center, Nijmegen, NetherlandsCharité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Pharmakovigilanzzentrum Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany0Service of Clinical Pharmacology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland1Materno-Fetal and Obstetrics Research Unit, Department “Woman-Mother-Child”, Lausanne University Hospital, Lausanne, Switzerland2Communication Department, Lausanne University Hospital, Lausanne, Switzerland3Institute of Humanities in Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland4Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland5Institute of Primary Healthcare (BIHAM), University of Bern, Bern, SwitzerlandMedication use during pregnancy is common, yet safety data remain limited, often leading to exaggerated risk perceptions and suboptimal care. Current communication practices are fragmented: product labeling and patient leaflets tend to emphasize potential harms, while specialized resources are underused. We explore the challenges of conveying accurate risk-benefit information and highlight the need for shared decision making. Integrated, evidence-based resources accessible to both healthcare providers and patients can reduce misinformation, improve adherence to essential treatments, and ultimately enhance maternal and child health. The Swiss MAMA-MEDS initiative illustrates how a unified knowledge base can align messaging, address health inequalities, and support patient-centered pregnancy care.https://www.frontiersin.org/articles/10.3389/fdsfr.2025.1712216/fullmedicationpregnancyrisk communicationshared decision makingpharmacovgilance |
| spellingShingle | Ursula Winterfeld Kenneth Hodson Kenneth Hodson Maya Berlin Benoît Marin Michael Ceulemans Michael Ceulemans Michael Ceulemans Corinna Weber-Schoendorfer François R. Girardin David Baud Béatrice Schaad Béatrice Schaad Alice Panchaud Alice Panchaud Communicating medication risks in pregnancy: Towards shared decision making medication pregnancy risk communication shared decision making pharmacovgilance |
| title | Communicating medication risks in pregnancy: Towards shared decision making |
| title_full | Communicating medication risks in pregnancy: Towards shared decision making |
| title_fullStr | Communicating medication risks in pregnancy: Towards shared decision making |
| title_full_unstemmed | Communicating medication risks in pregnancy: Towards shared decision making |
| title_short | Communicating medication risks in pregnancy: Towards shared decision making |
| title_sort | communicating medication risks in pregnancy towards shared decision making |
| topic | medication pregnancy risk communication shared decision making pharmacovgilance |
| url | https://www.frontiersin.org/articles/10.3389/fdsfr.2025.1712216/full |
| work_keys_str_mv | AT ursulawinterfeld communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT kennethhodson communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT kennethhodson communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT mayaberlin communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT benoitmarin communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT michaelceulemans communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT michaelceulemans communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT michaelceulemans communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT corinnaweberschoendorfer communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT francoisrgirardin communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT davidbaud communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT beatriceschaad communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT beatriceschaad communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT alicepanchaud communicatingmedicationrisksinpregnancytowardsshareddecisionmaking AT alicepanchaud communicatingmedicationrisksinpregnancytowardsshareddecisionmaking |